Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.9.2023MEDOCHEMIE Ltd. (MOE)3592EALMIRAL (sol inj 5x3ml/75 mg (amp.skl.hnedá))6.9.2023U
 11.9.2023MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))6.9.2023R
 11.9.2023MEDOCHEMIE Ltd. (MOE)39638ALMIRAL GEL (gel 1x100 g (tuba Al))6.9.2023O
 11.9.2023MEDOCHEMIE Ltd. (MOE)40200KLERIMED 250 mg (tbl flm 14x250 mg (blis.PVC/PVDC/Al))6.9.2023O
 11.9.2023MEDOCHEMIE Ltd. (MOE)67569MABRON 50 mg (cps dur 20x50 mg (blis.Al/PVC))6.9.2023O
 11.9.2023MEDOCHEMIE Ltd. (MOE)8708DBROXIVAN 6 mg/ml perorálny roztok (sol por 1x200 ml/1200 mg (fľ.skl.hnedá+plast.odmer.))6.9.2023O
 11.9.2023G.L. Pharma GmbH (GLH-2)7411BGerasa 100 mg gastrorezistentné tablety (tbl ent 100x100 mg (blis.PVC/Al))8.9.2023Z
 11.9.2023G.L. Pharma GmbH (GLH-2)68602Gerodorm (tbl 10x40 mg (blis.PVC/PVDC/Al))6.9.2023Z
 11.9.2023G.L. Pharma GmbH (GLH-2)20587Convulex CR 500 mg (tbl plg 100x500 mg (fľ.skl.hnedá))4.9.2023O
 11.9.2023Adamed Pharma S.A. (AFD)2961BRAMIZEK 5 mg/5 mg tvrdé kapsuly (cps dur 98x5 mg/5 mg (blis.PA/Al/PVC/Al))31.8.2023R
 11.9.2023Adamed Pharma S.A. (AFD)2983BRAMIZEK 10 mg/10 mg tvrdé kapsuly (cps dur 28x10 mg/10 mg (blis.PA/Al/PVC/Al))31.8.2023R
 11.9.2023Zentiva k.s. (ZNT-3)89295Bloonis 10 mg (tbl oro 28x10 mg (blis.OPA/Al/PVC/Al))18.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)2509DZetovar 10 mg/20 mg tablety (tbl 90x10 mg/20 mg (blis.OPA/Al/PVC))11.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)2513DZetovar 10 mg/40 mg tablety (tbl 90x10 mg/40 mg (blis.OPA/Al/PVC))11.9.2023O
 11.9.2023Zentiva, k.s. (ZNT-1)33494NEUROL 0,5 (tbl 30x0,5 mg (blis. PVC/PVDC/Al))12.9.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)